DGX

SELL

Quest Diagnostics Incorporated

Healthcare · Rank #262 · Analyzed Apr 20, 2026

$195.02

Current Price

$206.23

Intrinsic Value

+67.0%

Upside/Downside

2/10

Score

2/5

Quality

Analysis Summary

Valuation Consensus1/3 methods agree

Quality Score2/5.0

Framework RatingSELL

Price vs Intrinsic ValueUndervalued by 67.0%

Fair Value Range

Low$52.66

Base (IV)$206.23

High$325.72

Entry Points

Conservative$52.66

Moderate$129.44

Aggressive$206.23

Quality & Moat Breakdown

Return on Equity14.8% → 0.5/1.0

Debt LevelD/E 90 → 0/1.0

Revenue QualityGrowth 11.1%, margin Δ+0.9% +recovery → 1.0/1.0

Moat Strength1.0/5 → 0/1.0

Profit Margins9.0% → 0.5/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.